Key result
Qing Fei Hua Xian Decoction suppresses rat pulmonary fibrosis and inflammation by reducing oxidative stress.
Why the study?
The preventative effect of Qing Fei Hua Xian Decoction against pulmonary fibrosis and its mechanisms were investigated due to the need for novel clinical therapy options.
Does Qing Fei Hua Xian Decoction (QFHXD) ameliorate bleomycin-induced pulmonary fibrosis in rats?
Does Qing Fei Hua Xian Decoction (QFHXD) ameliorate bleomycin-induced pulmonary fibrosis in rats?
p-value: p=<0.05
QFHXD ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing oxidative stress and balancing the ACE-AngII-AT1R/ACE2-Ang-(1-7)-Mas axis.
Does not support clinical use of QFHXD; leaves open translation from rat models to human pulmonary fibrosis trials.
Objectives: We aimed to investigate the preventative effect of Qing Fei Hua Xian Decoction (QFHXD) against pulmonary fibrosis (PF) and its potential mechanisms. Materials and Methods: Bleomycin (BLM)-induced rats were respectively treated with 413.3, 826.6, and 1239.9 mg/kg of QFHXD and prednisone for 28 days. The lung tissues of rats were collected on day 28 for histological and western blotting analysis. Results: <0.05). Conclusion: QFHXD suppressed inflammatory infiltration and PF brought on by BLM in lung tissues through reducing oxidative stress by maintaining the equilibrium of ACE-AngII-AT1R and ACE2-Ang-(1-7) -Mas axes. This study may provide a novel clinical therapy option for PF.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) studied Pulmonary fibrosis. Qing Fei Hua Xian Decoction (QFHXD) vs. prednisone was evaluated on Inflammatory infiltration and pulmonary fibrosis (p=<0.05). Qing Fei Hua Xian Decoction suppressed inflammatory infiltration and pulmonary fibrosis in bleomycin-induced rats by reducing oxidative stress (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: